Robert C Williams1, Gerhard Opelz, Chelsea J McGarvey, E Jennifer Weil, Harini A Chakkera. 1. 1 Phoenix Epidemiology and Clinical Research Branch, NIH, NIDDK, Phoenix, AZ. 2 Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Heidelberg, Germany. 3 Mayo Clinic Hospital, Mayo Clinic, Phoenix, AZ. 4 Division of Nephrology, Mayo Clinic, Phoenix, AZ.
Abstract
BACKGROUND: Since the beginning of the technology, there has been active debate about the role of human leucocyte antigen (HLA) matching in kidney allograft survival. Recent studies have reported diminishing importance of HLA matching, which have, in turn, been challenged by reports that suggest the continuing importance of these loci. Given the controversies, we examined the effect of HLA compatibility on kidney allograft survival by studying all first adult kidney transplants in the United States from a deceased donor. METHODS: Using the United Network for Organ Sharing data, we identified first deceased donor kidney transplants between October 1, 1987, and December 31, 2013. Recipients were classified by their number of HLA mismatches. Cox multivariate regression analyses adjusting for recipient and donor transplant characteristics were performed to determine the impact of HLA compatibility on kidney allograft survival. RESULTS: Study cohort included 189 141 first adult kidney alone transplants, with a total of 994 558 years of kidney allograft follow-up time. Analyses adjusted for recipient and donor characteristics demonstrated a 13% higher risk (hazard ratio, 1.13; 95% confidence interval, 1.06-1.21) with 1 mismatch and a 64% higher risk (hazard ratio, 1.64, 95% confidence interval, 1.56-1.73) with 6 mismatches. Dividing the mismatch categories into 27 ordered permutations, and testing their 57 within mismatch category differences, demonstrated that all but 1 were equal, independent of locus. CONCLUSIONS: A significant linear relationship of hazard ratios was associated with HLA mismatch and affects allograft survival even during the recent periods of increasing success in renal transplantation.
BACKGROUND: Since the beginning of the technology, there has been active debate about the role of human leucocyte antigen (HLA) matching in kidney allograft survival. Recent studies have reported diminishing importance of HLA matching, which have, in turn, been challenged by reports that suggest the continuing importance of these loci. Given the controversies, we examined the effect of HLA compatibility on kidney allograft survival by studying all first adult kidney transplants in the United States from a deceased donor. METHODS: Using the United Network for Organ Sharing data, we identified first deceased donor kidney transplants between October 1, 1987, and December 31, 2013. Recipients were classified by their number of HLA mismatches. Cox multivariate regression analyses adjusting for recipient and donor transplant characteristics were performed to determine the impact of HLA compatibility on kidney allograft survival. RESULTS: Study cohort included 189 141 first adult kidney alone transplants, with a total of 994 558 years of kidney allograft follow-up time. Analyses adjusted for recipient and donor characteristics demonstrated a 13% higher risk (hazard ratio, 1.13; 95% confidence interval, 1.06-1.21) with 1 mismatch and a 64% higher risk (hazard ratio, 1.64, 95% confidence interval, 1.56-1.73) with 6 mismatches. Dividing the mismatch categories into 27 ordered permutations, and testing their 57 within mismatch category differences, demonstrated that all but 1 were equal, independent of locus. CONCLUSIONS: A significant linear relationship of hazard ratios was associated with HLA mismatch and affects allograft survival even during the recent periods of increasing success in renal transplantation.
Authors: A Goubella; N Broeders; J Racapé; A Hamade; A Massart; J-M Hougardy; A D Hoang; D Mikhalski; T Baudoux; F Gankam; P Madhoun; F Janssen; A Le Moine; J Nortier; P Vereerstraeten Journal: Acta Clin Belg Date: 2014-09-25 Impact factor: 1.264
Authors: Mirjam Laging; Judith A Kal-van Gestel; Jacqueline van de Wetering; Jan N M IJzermans; Willem Weimar; Joke I Roodnat Journal: Transplantation Date: 2014-11-15 Impact factor: 4.939
Authors: Stefan G Tullius; Huong Tran; Indira Guleria; Sayeed K Malek; Nicholas L Tilney; Edgar Milford Journal: Ann Surg Date: 2010-10 Impact factor: 12.969
Authors: Wai H Lim; Steve J Chadban; Philip Clayton; Charley A Budgeon; Kevin Murray; Scott B Campbell; Solomon Cohney; Graeme R Russ; Stephen P McDonald Journal: Clin Transplant Date: 2012-06-04 Impact factor: 2.863
Authors: Robert C Williams; Gerhard Opelz; E Jennifer Weil; Chelsea J McGarvey; Harini A Chakkera Journal: Transplantation Date: 2016-09 Impact factor: 4.939
Authors: Ankit Sharma; Anne Taverniti; Nicole Graf; Armando Teixeira-Pinto; Joshua R Lewis; Wai H Lim; Stephen I Alexander; Anne Durkan; Jonathan C Craig; Germaine Wong Journal: Pediatr Nephrol Date: 2020-02-17 Impact factor: 3.714
Authors: Dulat Bekbolsynov; Beata Mierzejewska; Jadwiga Borucka; Robert S Liwski; Anna L Greenshields; Joshua Breidenbach; Bradley Gehring; Shravan Leonard-Murali; Sadik A Khuder; Michael Rees; Robert C Green; Stanislaw M Stepkowski Journal: Front Immunol Date: 2020-10-29 Impact factor: 7.561